Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY-Reference-Cited by-同舟云学术

Incidence and management of inflammatory arthritis in England before and during the COVID-19 pandemic: a population-level cohort study using OpenSAFELY

Published:2022-12 Issue:12 Volume:4 Page:e853-e863
ISSN:2665-9913
Container-title:The Lancet Rheumatology
language:en
Short-container-title:The Lancet Rheumatology

Author:

Russell Mark D^ORCID,Galloway James B,Andrews Colm D,MacKenna Brian,Goldacre Ben,Mehrkar Amir,Curtis Helen J,Butler-Cole Ben,O'Dwyer Thomas,Qureshi Sumera,Ledingham Joanna M,Mahto Arti,Rutherford Andrew I,Adas Maryam A,Alveyn Edward,Norton Sam,Cope Andrew P,Bechman Katie

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy,Rheumatology

Reference26 articles.

1. Remission in psoriatic arthritis—where are we now?;Coates;Rheumatology (Oxford),2018

2. Treating rheumatoid arthritis early: a window of opportunity?;O'Dell;Arthritis Rheum,2002

3. Delayed diagnosis is linked to worse outcomes and unfavourable treatment responses in patients with axial spondyloarthritis;Seo;Clin Rheumatol,2015

4. Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study;Williams;Lancet Public Health,2020

5. Covid-19: A&E visits in England fall by 25% in week after lockdown;Thornton;BMJ,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The safety of antivirals and neutralising monoclonal antibodies used in prehospital treatment of Covid-19;Journal of Infection;2024-09

2. Association of immunomodulatory therapies with COVID-19 mortality in rheumatoid arthritis: An analysis of the FDA adverse event reporting system;Intelligent Pharmacy;2024-08

3. OpenSAFELY: The impact of COVID‐19 on azathioprine, leflunomide and methotrexate monitoring, and factors associated with change in monitoring rate;British Journal of Clinical Pharmacology;2024-04-08

4. Trust performance in managing inflammatory arthritis over time in England and Wales: a latent class analysis approach;RHEUMATOL ADV PRACT;2024

5. Disease-Modifying Medications in Patients with Rheumatoid Arthritis in the USA: Trends from 2016 to 2021;Drugs - Real World Outcomes;2024-02-18